NBCn1 and NHE1 expression and activity in ΔNErbB2 receptor-expressing MCF-7 breast cancer cells: Contributions to pHi regulation and chemotherapy resistance

Experimental Cell Research

Volumn 316, Issue 15, 2010, Pages 2538-2553

  Lauritzen, G ^a   Jensen, M B F ^a   Boedtkjer, E ^c   Dybboe, R ^a   Aalkjaer, C ^c   Nylandsted, J ^b   Pedersen, S F ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Chemotherapy; ErbB2; Na+ HCO3 cotransporter; Na+ H+ exchanger; Programmed cell death

Indexed keywords

CARRIER PROTEIN; CISPLATIN; PROTEIN DELTANERB2; PROTEIN NBCN1; RECEPTOR PROTEIN; SODIUM PROTON EXCHANGE PROTEIN 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 77955057718     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.06.005     Document Type: Article

References (60)

1. Aalkjaer C., Frische S., Leipziger J., Nielsen S., Praetorius J. Sodium coupled bicarbonate transporters in the kidney, an update. Acta Physiol. Scand. 2004, 181:505-512.
2. Ahmed S., Thomas G., Ghoussaini M., Healey C.S., Humphreys M.K., Platte R., Morrison J., Maranian M., Pooley K.A., Luben R., Eccles D., Evans D.G., Fletcher O., Johnson N., dos S.S., Peto I.J., Stratton M.R., Rahman N., Jacobs K., Prentice R., Anderson G.L., Rajkovic A., Curb J.D., Ziegler R.G., Berg C.D., Buys S.S., McCarty C.A., Feigelson H.S., Calle E.E., Thun M.J., Diver W.R., Bojesen S., Nordestgaard B.G., Flyger H., Dork T., Schurmann P., Hillemanns P., Karstens J.H., Bogdanova N.V., Antonenkova N.N., Zalutsky I.V., Bermisheva M., Fedorova S., Khusnutdinova E., Kang D., Yoo K.Y., Noh D.Y., Ahn S.H., Devilee P., van Asperen C.J., Tollenaar R.A., Seynaeve C., Garcia-Closas M., Lissowska J., Brinton L., Peplonska B., Nevanlinna H., Heikkinen T., Aittomaki K., Blomqvist C., Hopper J.L., Southey M.C., Smith L., Spurdle A.B., Schmidt M.K., Broeks A., van Hien R.R., Cornelissen S., Milne R.L., Ribas G., Gonzalez-Neira A., Benitez J., Schmutzler R.K., Burwinkel B., Bartram C.R., Meindl A., Brauch H., Justenhoven C., Hamann U., Chang-Claude J., Hein R., Wang-Gohrke S., Lindblom A., Margolin S., Mannermaa A., Kosma V.M., Kataja V., Olson J.E., Wang X., Fredericksen Z., Giles G.G., Severi G., Baglietto L., English D.R., Hankinson S.E., Cox D.G., Kraft P., Vatten L.J., Hveem K., Kumle M., Sigurdson A., Doody M., Bhatti P., Alexander B.H., Hooning M.J., van den Ouweland A.M., Oldenburg R.A., Schutte M., Hall P., Czene K., Liu J., Li Y., Cox A., Elliott G., Brock I., Reed M.W., Shen C.Y., Yu J.C., Hsu G.C., Chen S.T., nton-Culver H., Ziogas A., Andrulis I.L., Knight J.A., Beesley J., Goode E.L., Couch F., Chenevix-Trench G., Hoover R.N., Ponder B.A., Hunter D.J., Pharoah P.D., Dunning A.M., Chanock S.J., Easton D.F. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat. Genet. 2009, 41:585-590.
3. Atema A., Buurman K.J., Noteboom E., Smets L.A. Potentiation of DNA-adduct formation and cytotoxicity of platinum-containing drugs by low pH. Int.J. Cancer 1993, 54:166-172.
4. + exchanger gene expression: mitogenic stimulation increases NHE1 promoter activity. Am. J. Physiol. 1998, 274:C831-C839.
5. Boron W.F., Chen L., Parker M.D. Modular structure of sodium-coupled bicarbonate transporters. J. Exp. Biol. 2009, 212:1697-1706.
6. -. Am. J. Physiol. 1988, 255:C844-C856.
7. + exchanger in metastasis. Nat. Rev. Cancer 2005, 5:786-795.
8. Cardoso C.M., Groth-Pedersen L., Hoyer-Hansen M., Kirkegaard T., Corcelle E., Andersen J.S., Jaattela M., Nylandsted J. Depletion of kinesin 5B affects lysosomal distribution and stability and induces peri-nuclear accumulation of autophagosomes in cancer cells. PLoS ONE 2009, 4:e4424.
9. Ch'en F.F., Villafuerte F.C., Swietach P., Cobden P.M., Vaughan-Jones R.D. S0859, an N-cyanosulphonamide inhibitor of sodium-bicarbonate cotransport in the heart. Br. J. Pharmacol. 2008, 153:972-982.
10. Chen Y., Choong L.Y., Lin Q., Philp R., Wong C.H., Ang B.K., Tan Y.L., Loh M.C., Hew C.L., Shah N., Druker B.J., Chong P.K., Lim Y.P. Differential expression of novel tyrosine kinase substrates during breast cancer development. Mol. Cell. Proteomics 2007, 6:2072-2087.
11. Chiang Y., Chou C.Y., Hsu K.F., Huang Y.F., Shen M.R. EGF upregulates Na+/H+exchanger NHE1 by post-translational regulation that is important for cervical cancer cell invasiveness. J. Cell. Physiol. 2008, 214:810-819.
12. Christianson T.A., Doherty J.K., Lin Y.J., Ramsey E.E., Holmes R., Keenan E.J., Clinton G.M. NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer. Cancer Res. 1998, 58:5123-5129.
13. Cooper D.S., Yang H.S., He P., Kim E., Rajbhandari I., Yun C.C., Choi I. Sodium/bicarbonate cotransporter NBCn1/slc4a7 increases cytotoxicity in magnesium depletion in primary cultures of hippocampal neurons. Eur. J. Neurosci. 2009, 29:437-446.
14. Damkier H.H., Nielsen S., Praetorius J. An anti-NH2-terminal antibody localizes NBCn1 to heart endothelia and skeletal and vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H172-H180.
15. Egeblad M., Jaattela M. Cell death induced by TNF or serum starvation is independent of ErbB receptor signaling in MCF-7 breast carcinoma cells. Int.J. Cancer 2000, 86:617-625.
16. Egeblad M., Mortensen O.H., Jaattela M. Truncated ErbB2 receptor enhances ErbB1 signaling and induces reversible, ERK-independent loss of epithelial morphology. Int.J. Cancer 2001, 94:185-191.
17. Foghsgaard L., Wissing D., Mauch D., Lademann U., Bastholm L., Boes M., Elling F., Leist M., Jaattela M. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 2001, 153:999-1010.
18. Gatenby R.A., Gillies R.J. A microenvironmental model of carcinogenesis. Nat. Rev. Cancer 2008, 8:56-61.
19. + exchanger NHE1 by sustained intracellular acidosis. Evidence for a novel mechanism mediated by the ERK pathway. J. Biol. Chem. 2003, 278:31676-31684.
20. Hynes N.E., Lane H.A. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat. Rev. Cancer 2005, 5:341-354.
21. Janicke R.U. MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Res. Treat. 2008.
22. Karpinich N.O., Tafani M., Rothman R.J., Russo M.A., Farber J.L. The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c. J. Biol. Chem. 2002, 277:16547-16552.
23. Kroemer G., Jaattela M. Lysosomes and autophagy in cell death control. Nat. Rev. Cancer 2005, 5:886-897.
24. Kuin A., Aalders M., Lamfers M., van Zuidam D.J., Essers M., Beijnen J.H., Smets L.A. Potentiation of anti-cancer drug activity at low intratumoral pH induced by the mitochondrial inhibitor m-iodobenzylguanidine (MIBG) and its analogue benzylguanidine (BG). Br.J. Cancer 1999, 79:793-801.
25. + exchanger NHE1. J. Cell Sci. 2000, 113(Pt 20):3649-3662.
26. + -exchanger by CD95(Fas/Apo-1)-receptor stimulation. Pflugers Arch. 2000, 440:902-907.
27. Lauritzen G., Jensen M.B.F., Wiwel M., Nylandsted J., Aalkjaer C., Stock C., Schwab A., Pedersen S.F. pH regulatory ion transport in MCF-7 breast cancer cells: effects of truncated ErbB2 receptor expression on transporter expression and activity, and role in resistance to cisplatin-induced cell death. Acta Physiol. 2009, 195(Suppl. 669):O329.
28. Lauritzen G., Jensen M.F., Wiwel M., Nylandsted J., Aalkjaer C., Stock C., Schwab A., Pedersen S.F. Roles of pH-regulatory ion transport in motility and survival in MCF-7 breast cancer cells expressing constitutively active ErbB2. J. Physiol. Sci. 2009, 59(Suppl 1):490.
29. Malo M.E., Li L., Fliegel L. Mitogen-activated protein kinase-dependent activation of the Na+/H+exchanger is mediated through phosphorylation of amino acids Ser770 and Ser771. J. Biol. Chem. 2007, 282:6292-6299.
30. McLean L.A., Roscoe J., Jorgensen N.K., Gorin F.A., Cala P.M. Malignant gliomas display altered pH regulation by NHE1 compared with nontransformed astrocytes. Am. J. Physiol. Cell. Physiol. 2000, 278:C676-C688.
31. Meima M.E., Webb B.A., Witkowska H.E., Barber D. The Na-H exchanger NHE1 is an Akt substrate necessary for actin filament reorganization by growth factors. J. Biol. Chem. 2009.
32. Miller R.T., Counillon L., Pages G., Lifton R.P., Sardet C., Pouyssegur J. Structure of the 5′-flanking regulatory region and gene for the human growth factor-activatable Na/H exchanger NHE-1. J. Biol. Chem. 1991, 266:10813-10819.
33. Nylandsted J., Jaattela M., Hoffmann E.K., Pedersen S.F. Heat shock protein 70 inhibits shrinkage-induced programmed cell death via mechanisms independent of effects on cell volume-regulatory membrane transport proteins. Pflugers Arch. 2004, 449:175-185.
34. + exchanger NHE1 in stress-induced signal transduction: implications for cell proliferation and cell death. Pflugers Arch. 2006, 452:249-259.
35. + exchanger, NHE1, differentially regulates mitogen-activated protein kinase subfamilies after osmotic shrinkage in Ehrlich Lettre Ascites cells. Cell. Physiol. Biochem. 2007, 20:735-750.
36. Pedersen S.F., Jorgensen N.K., Damgaard I., Schousboe A., Hoffmann E.K. Mechanisms of pHi regulation studied in individual neurons cultured from mouse cerebral cortex. J. Neurosci. Res. 1998, 51:431-441.
37. Pedersen S.F., King S.A., Nygaard E.B., Rigor R.R., Cala P.M. NHE1 inhibition by amiloride- and benzoylguanidine-type compounds. Inhibitor binding loci deduced from chimeras of NHE1 homologues with endogenous differences in inhibitor sensitivity. J. Biol. Chem. 2007, 282:19716-19727.
38. Poulsen K.A., Pedersen S.F., Kolko M., Lambert I.H. Induction of group VIA phospholipase A2 activity during in vitro ischemia in C2C12 myotubes is associated with changes in the level of its splice variants. Am. J. Physiol. Cell Physiol. 2007, 293:C1605-C1615.
39. Rasmussen M., Alexander R.T., Darborg B.V., Mobjerg N., Hoffmann E.K., Kapus A., Pedersen S.F. Osmotic cell shrinkage activates ezrin/radixin/moesin (ERM) proteins: activation mechanisms and physiological implications. Am. J. Physiol. Cell Physiol. 2008, 294:C197-C212.
40. Rebillard A., Tekpli X., Meurette O., Sergent O., LeMoigne-Muller G., Vernhet L., Gorria M., Chevanne M., Christmann M., Kaina B., Counillon L., Gulbins E., Lagadic-Gossmann D., Dimanche-Boitrel M.T. Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells. Cancer Res. 2007, 67:7865-7874.
41. + exchanger (NHE) NHE isoform 1 in human breast cancer cells. Clin. Cancer Res. 2003, 9:2366-2373.
42. Rhodes D.R., Yu J., Shanker K., Deshpande N., Varambally R., Ghosh D., Barrette T., Pandey A., Chinnaiyan A.M. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 2004, 6:1-6.
43. + exchanger. Blood 2000, 95:1427-1434.
44. Roskoski R. The ErbB/HER receptor protein-tyrosine kinases and cancer. Biochem. Biophys. Res. Commun. 2004, 319:1-11.
45. Ross J.S., Fletcher J.A., Bloom K.J., Linette G.P., Stec J., Symmans W.F., Pusztai L., Hortobagyi G.N. Targeted therapy in breast cancer: the HER-2/neu gene and protein. Mol. Cell. Proteomics 2004, 3:379-398.
46. Santner S.J., Dawson P.J., Tait L., Soule H.D., Eliason J., Mohamed A.N., Wolman S.R., Heppner G.H., Miller F.R. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res. Treat. 2001, 65:101-110.
47. Scaltriti M., Rojo F., Ocana A., Anido J., Guzman M., Cortes J., Di C.S., Matias-Guiu X., Cajal S., Arribas J., Baselga J. Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer. J. Natl Cancer Inst. 2007, 99:628-638.
48. Schelling J.R., Abu Jawdeh B.G. Regulation of cell survival by Na+/H+exchanger-1 (NHE1). Am. J. Physiol. Ren. Physiol. 2008.
49. Schneider L., Stock C.M., Dieterich P., Jensen B.H., Pedersen L.B., Satir P., Schwab A., Christensen S.T., Pedersen S.F. The Na+/H+exchanger NHE1 is required for directional migration stimulated via PDGFR-alpha in the primary cilium. J. Cell Biol. 2009, 185:163-176.
50. Siddik Z.H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003, 22:7265-7279.
51. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., McGuire W.L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235:177-182.
52. Slamon D.J., Godolphin W., Jones L.A., Holt J.A., Wong S.G., Keith D.E., Levin W.J., Stuart S.G., Udove J., Ullrich A. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989, 244:707-712.
53. Steffan J.J., Snider J.L., Skalli O., Welbourne T., Cardelli J.A. Na+/H+exchangers and RhoA regulate acidic extracellular pH-induced lysosome trafficking in prostate cancer cells. Traffic 2009, 10:737-753.
54. + exchanger NHE1 in cell migration. Acta Physiol. 2006, 187:149-157.
55. Stuwe L., Muller M., Fabian A., Waning J., Mally S., Noel J., Schwab A., Stock C. pH dependence of melanoma cell migration: protons extruded by NHE1 dominate protons of the bulk solution. J. Physiol. 2007, 585:351-360.
56. + exchanger isoform-1. J. Biol. Chem. 1999, 274:20206-20214.
57. Thangaraju M., Sharma K., Liu D., Shen S.H., Srikant C.B. Interdependent regulation of intracellular acidification and SHP-1 in apoptosis. Cancer Res. 1999, 59:1649-1654.
58. Vasiljeva O., Turk B. Dual contrasting roles of cysteine cathepsins in cancer progression: apoptosis versus tumour invasion. Biochimie 2008, 90:380-386.
59. Wong P., Kleemann H.W., Tannock I.F. Cytostatic potential of novel agents that inhibit the regulation of intracellular pH. Br.J. Cancer 2002, 87:238-245.
60. Zeidan Y.H., Jenkins R.W., Hannun Y.A. Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathway. J. Cell Biol. 2008, 181:335-350.